Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.
about
In Vivo Rodent Models of Skeletal Muscle Adaptation to Decreased UseAerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesOptimizing IGF-I for skeletal muscle therapeuticsInterleukin-6 myokine signaling in skeletal muscle: a double-edged sword?Cellular and molecular mechanisms of muscle atrophyMolecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Role of IGF-I signaling in muscle bone interactionsThe renin-angiotensin system and prevention of age-related functional decline: where are we now?Glucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoidsReactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases.PGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice.Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profileProteasome inhibitors and cardiac cell growthUrea-induced ROS generation causes insulin resistance in mice with chronic renal failure.Protein calorie malnutrition, nutritional intervention and personalized cancer care.A limited role for PI(3,4,5)P3 regulation in controlling skeletal muscle mass in response to resistance exercise.Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophyAngiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3β Signaling Pathway.Satellite cells and the muscle stem cell nicheIGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.PTEN inhibition improves muscle regeneration in mice fed a high-fat diet.Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patientsCrossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity.The link of unintentional weight loss to cardiac event-free survival in patients with heart failureAngiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy1-Sarcosine-angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat modelAngiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration.A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failureMaking the case for skeletal myopathy as the major limitation of exercise capacity in heart failureMechanisms of muscle wasting in chronic kidney diseaseChronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and functionProteasome inhibition improves diaphragm function in congestive heart failure rats.Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and functionAngiotensin II induced catabolic effect and muscle atrophy are redox dependent.The regulation of muscle mass by endogenous glucocorticoids.Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wastingInhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia
P2860
Q26753187-142B513A-9CBD-41F0-9536-9C6C34184154Q26767412-7DBFBA15-14B3-4F2E-82E5-38C8A276E84CQ26825444-5E9EC03D-EE26-4999-906F-868C0B5D78DBQ26866208-C46C8B90-DA6D-462D-B4B5-CD7DD1195904Q27012762-76A76F76-301B-41A6-BDA8-939D327834B6Q28068034-CE9FED32-0549-4583-BF91-95298737AD13Q28082188-A3094A44-BD64-4EDC-80A8-7013EEE486A1Q28085528-A50CBDD3-6870-4975-814B-4D314523F078Q28509978-26C6FEFF-1DE1-4D3F-866B-C92F4EBED29AQ30275433-58B25918-96CA-4802-8689-8AD9F77B6A91Q30427538-FB9AB76A-FC4A-459D-B0BA-84DC86F6AFC6Q30440296-76E01162-BC4F-4EF1-A889-545458282901Q33554490-7D1FC707-F2AC-411E-9590-FB369D6701DFQ33559582-93E5B607-46A2-4206-896B-48F755FEE63FQ33618955-E746586E-8048-4E25-B22B-D96B03BF7E46Q33641237-80E9E3FC-D41B-4C23-A162-BCBB6BA68B72Q33702390-E8613813-D289-48A4-8077-80DA232936DEQ33809770-0FF420D5-35E7-4C32-9252-719ECCFCBF31Q33816665-9A45BC94-7800-4E34-9B3C-0B907AB71E0CQ33840703-E53FDAA3-C21C-402F-8A51-BCFFA0D86955Q33869719-3D7515BD-F1A6-440B-8785-060D2649BEF3Q33869877-994D0B6A-D3BD-43EF-8B55-D0036A5D5442Q33885504-87ED44F4-655D-4438-B9DC-CBE8BCDDA5FEQ33901722-4D13FA7E-351C-4E44-8567-46CEA77B7894Q33967411-ECBF4C50-559B-4040-A25F-A836E5C5EA7AQ34036472-0B4AD78D-C9A8-4358-9600-FFFCDFC0EF8CQ34140453-84F70894-1C90-4A3A-BFB0-0D551617FFD0Q34156951-CA1597A8-72BA-4F30-86A9-11D4C13C7A94Q34248966-1D2DDBA0-5702-4930-AA16-2AFA8E56D0D3Q34299825-A83FE71B-5999-42B4-BC4C-9B3831BD8205Q34590981-71CB0FA4-B046-4B0F-9E93-73B3ABA84216Q34667465-4974562B-EE67-4174-8475-D3885FD145BDQ34723810-A788719F-6BBA-4ED9-BB68-4B87DD8EE3CBQ34785071-A24D89F4-CBBD-4225-B770-8109730F5755Q35005523-0D55279E-41EF-40B9-B071-251E11255943Q35011884-542DEB82-B496-44A0-A7AA-A8F7FACE491AQ35028013-62C76018-ED18-46D3-8C82-EB4F555A1494Q35042169-4A2B078A-E5A7-47A4-AF8B-D24D005D1D9EQ35240148-AEA5C450-87FB-4B1F-81E9-97EE83FCADC6Q35536351-BF7C74DF-EA3C-46CC-8075-4E84E44F98E6
P2860
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Muscle-specific expression of ...... duced skeletal muscle wasting.
@en
type
label
Muscle-specific expression of ...... duced skeletal muscle wasting.
@en
prefLabel
Muscle-specific expression of ...... duced skeletal muscle wasting.
@en
P2093
P2860
P356
P1476
Muscle-specific expression of ...... duced skeletal muscle wasting.
@en
P2093
Patrick Delafontaine
William E Mitch
Yangxin Li
Yao-Hua Song
P2860
P304
P356
10.1172/JCI22324
P407
P577
2005-02-01T00:00:00Z